ADL
LEGN icon

Asset Dedication LLC’s Legend Biotech LEGN Stock Holding History

Asset Dedication LLC’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-379
Closed -$12.9K – 1207
2025
Q1 		$12.9K Hold
379
– – ﹤0.01% 730
2024
Q4 		$12.3K Hold
379
– – ﹤0.01% 735
2024
Q3 		$18.5K Hold
379
– – ﹤0.01% 702
2024
Q2 		$16.8K Hold
379
– – ﹤0.01% 718
2024
Q1 		$21K Sell
379
-384
-50% -$23.2K ﹤0.01% 584
2023
Q4 		$46K Hold
763
– – ﹤0.01% 443
2023
Q3 		$51K Hold
763
– – ﹤0.01% 425
2023
Q2 		$53K Hold
763
– – ﹤0.01% 430
2023
Q1 		$37K Hold
763
– – ﹤0.01% 463
2022
Q4 		$38K Hold
763
– – ﹤0.01% 454
2022
Q3 		$31K Hold
763
– – ﹤0.01% 461
2022
Q2 		$42K Hold
763
– – 0.01% 234
2022
Q1 		$28K Hold
763
– – ﹤0.01% 506
2021
Q4 		$36K Hold
763
– – ﹤0.01% 460
2021
Q3 		$39K Hold
763
– – 0.01% 459
2021
Q2 		$31K Buy
+763
New +$25.9K ﹤0.01% 471

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Asset Dedication LLC's LEGN Position: Q2 2025 in Review

Asset Dedication LLC sold out of Legend Biotech (LEGN) in Q2 2025, closing a stake of 379 shares — an estimated $12.9K sold.

Asset Dedication LLC first reported a position in LEGN in Q2 2021 and held it in 16 quarters. The position peaked at $53K in Q2 2023. 211 funds tracked by Wall St. Rank hold LEGN as of Q2 2025.

  • Asset Dedication LLC reported no remaining Legend Biotech position as of Q2 2025 after selling out during the quarter.
  • Asset Dedication LLC sold 379 Legend Biotech shares in Q2 2025, an estimated $12.9K.
  • Asset Dedication LLC first reported a position in Legend Biotech in Q2 2021 and held it in 16 quarters.
  • Asset Dedication LLC's Legend Biotech position peaked at $53K in Q2 2023.
  • 211 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2025.

Based on Asset Dedication LLC's 13F filing for Q2 2025, filed 19 Aug 2025.